loadpatents
Patent applications and USPTO patent grants for Heavner; George.The latest application filed is for "anti-il-12 antibodies, epitopes, compositions, methods and uses".
Patent | Date |
---|---|
Anti-IL-12 Antibodies, Epitopes, Compositions, Methods and Uses App 20190085069 - Giles-Komar; Jill ;   et al. | 2019-03-21 |
Anti-IL-12 Antibodies, Epitopes, Compositions, Methods and Uses App 20180079809 - Giles-Komar; Jill ;   et al. | 2018-03-22 |
Method of treating lupus by administering an anti-IL-12 antibody Grant 9,862,766 - Giles-Komar , et al. January 9, 2 | 2018-01-09 |
Anti-TNF antibodies, compositions, methods and uses Grant 9,828,424 - Heavner , et al. November 28, 2 | 2017-11-28 |
Method of Treating Lupus By Administering An Anti-IL-12 Antibody App 20170157247 - Giles-Komar; Jill ;   et al. | 2017-06-08 |
Nucleic acids encoding anti-IL-12 antibody Grant 9,605,067 - Giles-Komar , et al. March 28, 2 | 2017-03-28 |
Anti-IL-12 Antibody Nucleic Acids and Methods App 20160319014 - Giles-Komar; Jill ;   et al. | 2016-11-03 |
Anti-tnf Antibodies, Compositions, Methods And Uses App 20160264659 - Heavner; George ;   et al. | 2016-09-15 |
Method of treating Crohn's disease by administering an anti-IL-12 antibody Grant 9,428,579 - Giles-Komar , et al. August 30, 2 | 2016-08-30 |
Anti-TNF antibodies, compositions, methods and uses Grant 9,321,836 - Heavner , et al. April 26, 2 | 2016-04-26 |
Method of Treating Crohn's Disease By Administering An Anti-IL-12 Antibody App 20150030608 - Giles-Komar; Jill ;   et al. | 2015-01-29 |
Method for treating psoriatic arthritis by administering an anti-IL-12 antibody Grant 8,894,990 - Giles-Komar , et al. November 25, 2 | 2014-11-25 |
Anti- Tnf Antibodies, Compositions, Methods And Uses App 20140161816 - Heavner; George ;   et al. | 2014-06-12 |
Melanocortin Receptor Binding Conjugates App 20140050745 - Heavner; George | 2014-02-20 |
Fusion proteins of alpha-MSH derivatives and Fc Grant 8,614,185 - Heavner December 24, 2 | 2013-12-24 |
Anti-TNF antibodies, compositions, methods and uses Grant 8,603,778 - Heavner , et al. December 10, 2 | 2013-12-10 |
Method for Treating Psoriatic Arthritis By Administering An Anti-IL-12 Antibody App 20130129617 - Giles-Komar; Jill ;   et al. | 2013-05-23 |
Method for treating psoriasis by administering an anti-IL-12 antibody Grant 8,329,170 - Giles-Komar , et al. December 11, 2 | 2012-12-11 |
Anti- Tnf Antibodies, Compositions, Methods And Uses App 20120282170 - Heavner; George ;   et al. | 2012-11-08 |
Method for Treating Psoriasis by Administering An Anti-IL-12 Antibody App 20120207670 - Giles-Komar; Jill ;   et al. | 2012-08-16 |
Anti-TNF antibodies, compositions, methods and uses Grant 8,241,899 - Heavner , et al. August 14, 2 | 2012-08-14 |
Semi-Synthetic GLP-1 Peptide-FC Fusion Constructs, Methods and Uses App 20120189627 - Heavner; George | 2012-07-26 |
Anti-IL-12 antibodies Grant 8,080,247 - Giles-Komar , et al. December 20, 2 | 2011-12-20 |
Melanocortin Receptor Binding Conjugates App 20100278845 - Heavner; George | 2010-11-04 |
Anti-TNF antibodies, compositions, methods and uses Grant 7,820,169 - Heavner , et al. October 26, 2 | 2010-10-26 |
Anti-TNF antibodies, compositions, methods and uses Grant 7,815,909 - Heavner , et al. October 19, 2 | 2010-10-19 |
Solution phase biopanning method using engineered decoy proteins Grant 7,790,405 - O'Neil , et al. September 7, 2 | 2010-09-07 |
Anti-TNF antibodies, compositions, methods and uses Grant 7,691,378 - Heavner , et al. April 6, 2 | 2010-04-06 |
Anti-TNF Antibodies, Compositions, Methods and Uses App 20090252743 - Heavner; George ;   et al. | 2009-10-08 |
Anti-IL-12 Antibodies, Epitopes, Compositions, Methods and Uses App 20090202549 - Giles-Komar; Jill ;   et al. | 2009-08-13 |
Semi-Synthetic GLP-1 Peptide-FC Fusion Constructs, Methods and Uses App 20090181037 - Heavner; George | 2009-07-16 |
Anti-IL-12/23p40 Antibodies, Epitopes, Formulations, Compositions, Methods and Uses App 20090181027 - Dal Monte; Paul ;   et al. | 2009-07-16 |
Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses Grant 7,547,767 - Yang , et al. June 16, 2 | 2009-06-16 |
Anti-TNF antibodies, compositions, methods and uses Grant 7,521,206 - Heavner , et al. April 21, 2 | 2009-04-21 |
Anti-tnf Antibodies, Compositions, Methods And Uses For Treatment Of Depression And Related Conditions App 20090081234 - Heavner; George ;   et al. | 2009-03-26 |
Anti-TNF Antibodies, Compositions, Methods and Uses App 20090081241 - Heavner; George ;   et al. | 2009-03-26 |
Anti-TNF Antibodies, Compositions, Methods and Uses App 20090074794 - Heavner; George ;   et al. | 2009-03-19 |
Anti-dual integrin antibodies, compositions, methods and uses Grant 7,288,390 - Heavner , et al. October 30, 2 | 2007-10-30 |
Anti-TNF antibodies, compositions, methods and uses Grant 7,250,165 - Heavner , et al. July 31, 2 | 2007-07-31 |
Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses App 20070128200 - Yang; Jing ;   et al. | 2007-06-07 |
Methods of Preparing Targeted Immunoliposomes App 20070092558 - Heavner; George ;   et al. | 2007-04-26 |
Anti-TNF antibodies, compositions, methods and uses App 20070003548 - Heavner; George ;   et al. | 2007-01-04 |
Method for generating monoclonal antibodies App 20060246061 - MBow; M. Lamine ;   et al. | 2006-11-02 |
Erythropoietin conjugate compounds with extended half-lives Grant 7,074,755 - Heavner July 11, 2 | 2006-07-11 |
Solution phase biopanning method using engineered decoy proteins App 20050239140 - O'neil, Karyn ;   et al. | 2005-10-27 |
Anti-TNF antibodies, compositions, methods and uses App 20050123541 - Heavner, George ;   et al. | 2005-06-09 |
Erythropoietin conjugate compounds with extended half-lives App 20040229318 - Heavner, George | 2004-11-18 |
Method for generating monoclonal antibodies App 20030235891 - MBow, M. Lamine ;   et al. | 2003-12-25 |
Anti-TNF antibodies, compositions, methods and uses App 20030049725 - Heavner, George ;   et al. | 2003-03-13 |
Anti-dual integrin antibodies, compositions, methods and uses App 20030040044 - Heavner, George ;   et al. | 2003-02-27 |
Tetra and penta-peptides useful in regulating the immune system Grant 5,298,490 - Heavner , et al. March 29, 1 | 1994-03-29 |
B cell differentiating peptides and conjugates thereof Grant 4,866,121 - Audhya , et al. * September 12, 1 | 1989-09-12 |
B-cell differentiating peptides Grant 4,783,442 - Audhya , et al. * November 8, 1 | 1988-11-08 |
Conformationally restricted thymopentin-like compounds Grant 4,547,489 - Goldstein , et al. October 15, 1 | 1985-10-15 |
Enzyme-resistant immunomodulatory peptides Grant 4,505,853 - Goldstein , et al. March 19, 1 | 1985-03-19 |
Peptides having thymopoietin-like activity Grant 4,397,842 - Goldstein , et al. August 9, 1 | 1983-08-09 |
N-Protected pentapeptides useful as intermediates in the preparation of thymopoietin pentapeptide Grant 4,369,137 - Heavner January 18, 1 | 1983-01-18 |
Methods and compositions for preparation of H-ARG-X-Z-Y-TYR-R Grant 4,298,523 - Heavner November 3, 1 | 1981-11-03 |
Immunoregulatory diketopiperazine compounds Grant 4,289,759 - Heavner , et al. September 15, 1 | 1981-09-15 |
Method and composition for preparation of H-SAR-LYS-SAR-GLN-NH.sub.2 Grant 4,250,086 - Heavner February 10, 1 | 1981-02-10 |
Peptides having ubiquitin-like activity Grant 4,215,111 - Goldstein , et al. July 29, 1 | 1980-07-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.